Stereotactic laser ablation of high-grade gliomas

Ammar H Hawasli1, Albert H Kim, Gavin P Dunn

  • 1Departments of Neurosurgery.

Neurosurgical Focus
|December 2, 2014
PubMed

Insights

Stereotactic laser interstitial thermal therapy (LITT) offers a focal treatment for high-grade gliomas (HGGs). This review explores LITT

Area of Science:

  • Neurosurgery
  • Oncology
  • Medical Technology

Background:

  • Surgical cytoreduction is crucial for improving prognosis in high-grade glial neoplasms.
  • Advances in intraoperative imaging enable precise interventions for intracranial lesions.
  • High-grade gliomas (HGGs) remain challenging tumors with significant unmet needs.

Purpose of the Study:

  • To review the current research on stereotactic laser interstitial thermal therapy (LITT) for HGG treatment.
  • To explore the integration of LITT into clinical practice for managing HGGs.
  • To propose a management algorithm incorporating LITT for HGGs.

Main Methods:

  • Comprehensive literature review of studies utilizing stereotactic LITT for high-grade gliomas.
  • Analysis of technological advancements in intraoperative imaging and neuro-oncology.
  • Synthesis of research findings to inform a clinical management strategy.

Main Results:

  • Stereotactic LITT is emerging as a viable focal treatment option for HGGs.
  • The application of LITT is supported by progress in adjuvant therapies and molecular understanding of gliomas.
  • LITT complements existing treatment modalities for HGGs.

Conclusions:

  • Stereotactic LITT represents a significant advancement in the focal treatment of high-grade gliomas.
  • A proposed management algorithm can guide the incorporation of LITT into HGG treatment paradigms.
  • Further research and clinical integration of LITT hold promise for improving HGG patient outcomes.

Related Concept Videos